MEANS USED IN EPILEPSY (LITERATURE REVIEW).
Abstract
The mechanism of action of anticonvulsants has not been fully studied. These drugs mainly prevent the spread (generalization) of impulses in an epileptic center, because their use reduces the amount of neurotransmitters (glutamide) and increases the amount of neurotransmitters (GAMK) in the brain, reducing the transmission of impulses between neurons. Such changes in neurotransmitters reduce the sensitivity of neurons and prolong their refractory period. Of course, changes in the activity of ATPases, which control the exchange of ions in the nerve endings, are of particular importance. Antiepileptic drugs do not completely eliminate seizures, but due to regular and continuous consumption, they stop the exacerbation of the disease by reducing and reducing the attacks and ensure the ability of patients to work. But if you suddenly stop taking the drug and suddenly reduce the dose, there is a risk of worsening of the disease and turning into epileptic status.
References
Caviness JN. Treatment of myoclonus. Neurotherapeutics. 2014 Jan;11(1):188-200. doi: 10.1007/s13311-013-0216-3. PMID: 24037428; PMCID: PMC3899494.
https://en.wikipedia.org/wiki/Anticonvulsant
Blank R. Antikonvulsiva und ihre psychischen Wirkungen--eine Ubersicht [Anticonvulsants and their psychological effects--a review]. Fortschr Neurol Psychiatr. 1990 Jan;58(1):19-32. German. doi: 10.1055/s-2007-1001167. PMID: 2407625.
Харкевич, Дмитрий Александрович. "Основы фармакологии." (2015): 720-720.
Katzung BG, Masters SB Trevor, AJ, eds. (2004). Basic & Clinical Pharmacology.
Meyer FP, Walther H. Zur Beeinflussung der psychophysischen Leistungsfähigkeit des Menschen durch Antiepileptika [Modification of psychophysical performance of the human by anticonvulsants]. Psychiatr Neurol Med Psychol (Leipz). 1987 Jan;39(1):1-16. German. PMID: 3108914.
Riss J. et al. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics //Acta neurologica scandinavica. – 2008. – Т. 118. – №. 2. – С. 69-86.
Manning, Jon-Paul A., Douglas A. Richards, and Norman G. Bowery. "Pharmacology of absence epilepsy." Trends in Pharmacological Sciences 24.10 (2003): 542-549.
Gaston, Tyler E., and Daniel Friedman. "Pharmacology of cannabinoids in the treatment of epilepsy." Epilepsy & Behavior 70 (2017): 313-318.
Ghosh, S., Sinha, J. K., Khan, T., Devaraju, K. S., Singh, P., Vaibhav, K., & Gaur, P. (2021). Pharmacological and therapeutic approaches in the treatment of epilepsy. Biomedicines, 9(5), 470.
